The Macrophage Electrophoretic Mobility (MEM) test (Field and Caspary, 1970) can distinguish healthy control subjects from patients who have malignant disease with a remarkable absence of overlap, a rare feature in a biologically based test (Pritchard et al., 1972; Field, Caspary and Smith, 1973 ; Preece and Light, 1974) . However, the acceptability of an in vitro cancer test depends upon its success in detecting malignant disease against a wide spectrum of advanced or chronic non-malignant conditions. When tested in this way, many claims for diagnostic cancer tests have not been substantiated. It has already been shown ) that diseases such as sarcoidosis, Crohn's disease, ulcerative colitis, intrinsic asthma, myasthenia gravis and certain neurological conditions can produce lymphocyte sensitization to myelin basic protein (MBP), the antigen used to elicit the response in the MEM test and its derivative MOD-MEM (Pritchard et al., 1973a) . This paper presents the results of a study undertaken to assess the performance of the MOD-MEM test in distinguishing cancer subjects from a control series of patients hospitalized with non-malignant diseases.
MATERIALS AND METHODS
Lymphocyte preparation and the production of guinea-pig macrophages have been described elsewhere (Pritchard et al., 1973b) . Because the test material for this investigation was obtained from a general hospital at a considerable distance from the base laboratory, defibrinated blood samples prepared immediately after venipuncture were stored at 4°C overnight in tissue culture medium 199 with 10% added autologous serum. Before use in the MOD-MEM assay, the cell suspensions were washed 3 times by centrifugation at 350 g in TC 199 to ensure removal of serum constituents. Aliquots containing 106 lymphocytes in 3 ml were then incubated with 100 ,ug of MBP under the split incubation conditions of the MOD-MEM test (Pritchard et al., 1973b (Shenton, Hughes and Field, 1973) . The double column system of recording results (Pritchard et al., 1972 (Pritchard et al., , 1973a (Pritchard et al., and 1973b Both of these conditions are associated with degeneration of nerve tissue, and lymphocyte sensitization to myelin basic protein can be expected . The frequent occurrence of such examples in an investigation of this nature makes a clear demarcation between disease groups difficult. One out of 5 asthmatic subjects gave a positive result. Clinical evidence suggested that this particular patient (Table II) was suffering from intrinsic asthma, which has been shown to give MEM+ results (Caspary, Feinman and Field, 1973) . The other 4 asthma cases (Table I) were clinically classified as extrinsic asthma.
Results within the positive range were found for the diseases listed in Table II Tables I or II. St  positive results in Table IIL continuing clinical review.
follow-up, 9 months after the i the patient listed as sufl dysphagia (Table III) and so on. From graphs of the registration rates per 100,000 males or females, plotted against age, it is possible in this way to estimate the fractional contribution to be expected from each male or female individual in the actual series towards the final total of unexplained positives, assuming any specified number of years of average 'early warning'.
For the purpose of this analysis, the group of 6 patients in hospital for the investigation of breast lumps were excluded from the series, on the grounds that they were a selected group already under an unknown degree of 'high risk' for malignant disease, and therefore not subject to the 'normal' cancer registration rates. Similarly, the first 23 patients from Table II were excluded on the grounds that any positive results due to pre-clinical malignant disease in this group would be masked by the fact that their test results were already positive from the conditions for which they were hospitalized. The 11 malignant subjects deliberately introduced as a check on the operation of the test were not part of the control series, leaving a final group of 38 males and 38 females available for the estimation of unexplained positive rates due to possible pre-clinical malignant disease. The numbers in this final group are too small for an adequate level of statistical confidence in the result, and therefore no attempt has been made to correct for secondary factors. These factors can be expected to reduce the accuracy of the prediction mainly for stibjects of advanced age. The South Wales cancer registration rates for represent the most relevant data available for the control series under study, but are now known to have been too low in the years immediately following the establishment of the registry. Therefore corrections were applied to update the figures to the year of the test, with a further small estimated correction for the rate of increase expected in the future. A more detailed account of the derivation of the unexplained positive rates to be expected if the test detects preclinical cancer will be published separately (Sutherland, Pritchard and Smith).
The figure shows the numbers of unexplained positives predicted for that fraction of the 76 subjects above each specified age, plotted (solid lines) for 'early warning' periods of 15, 16 and 17 years. The 13 positives from (Pritchard, Henk and Hart, unpub.) . Therefore, at the time of the test a patient may be under investigation for a disease which itself does not give rise to lymphocyte sensitization, but a positive result is obtained due to a previous illness which caused sensitization to the antigen under study.
The test has been described as technically difficult to perform, but our experience has shown that the difficulties largely disappear with rigid adherence to the recommended principles and precautions (Pritchard et al., 1973a, b; Goldstone, Kerr and Irvine, 1973; Tognella et al., 1974; Meyer-Rienecker et al., 1974 (Field and Shenton, 1975) . Mass screening of large sections of the general population for malignant disease is not practical until a more refined and automated technique has been developed, together with a suitable backup system adapted for more specific investigation and tumour localization.
